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Implication for health policy/practice/research/medical education:
This Clinical trial revealed that ginger might be useful in coronary angioplasty and a candidate as a possible prospective natural 
drug for this purpose.
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Introduction: Evidence from animal studies suggests that Zingiber officinale (ginger) may 
help prevent ischemia–reperfusion injury (IRI) in heart. The aim of the present study was to 
investigate the effect of ginger on inducing preconditioning on patients undergoing angioplasty. 
Methods: Thirty-four patients, referred for elective angioplasty, were randomly divided into 
the control (17 patients) and ginger groups (17 patients). Subjects in the experimental group 
were provided 250 mg ginger powder in Zintoma capsules per day for 10 days, whereas those 
in the control group received placebo. The patients underwent percutaneous transluminal 
coronary angioplasty (PTCA) (One 45-second balloon inflation and 2 minutes reperfusion). 
Chest pain scores were assessed immediately after angioplasty and cardiac injury biomarkers 
were assessed 12 hours later. 
Results: The average pain score during the balloon inflation in the ginger group was 
significantly lower than the control group (2.1±1 versus 3.8±1.5, P = 0.04). Troponin I was 
elevated in both groups after angioplasty, but there was not any significant difference between 
groups in this regard (P = 0.12 and 0.10, respectively). 
Conclusion: The use of ginger reduces chest pain during coronary angioplasty but its effect 
on the release of biochemical markers of myocardial damage is obscure.
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A B S T R A C T
Introduction
Ischemia–reperfusion injury (IRI) occurs after the 
treatment of myocardial infarction and other elective 
procedures such as open heart surgery and coronary 
angioplasty (1). The most important theory to reduce IRI 
is ischemic preconditioning (IPC) introduced by Murry 
et al who suggested that the short episodes of ischemia-
reperfusion increase myocardial tolerance to long periods 
of severe ischemia and reperfusion after cardiac events (2). 
Preconditioning has two windows of protection. The first 
begins immediately after the treatment and lasts for 1 to 2 
hours, whereas the second begins 12 hours after ischemia 
and lasts for 72 to 96 hours (3). A number of approaches 
have been developed that mimic IPC. Some of the more 
important pharmacological agents that have been studied 
include adenosine, bradykinin and opioids (4-6). 
The ginger (Zingiber officinale Roscoe) has exerted 
potential protective effects against IRI in animal models 
(7,8). Ginger is a tropical plant which has been cultivated 
for thousands of years as a spice and medicinal purposes 
in South-East Asia and other parts of the world (9). 
Also both animal and human studies have shown that 
ginger have many other therapeutic effects such as anti-
inflammatory, antioxidant, antihypertensive, anti-platelet, 
positive inotropic and lowering glucose, cholesterol and 
other lipid profile in cardiovascular diseases (10-14). 
Percutaneous coronary angioplasty (PTCA) is a clinical 
setting with mandatory episodes of ischemia reperfusion 
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and is generally believed that this model resembles 
experimental animal models more closely than the acute 
myocardial infarction clinical models (15). Therefore, 
the present study was designed to analyze the possible 
protective effect of ginger against regional ischemic 
reperfusion (I/R) injury in patients undergoing coronary 
angioplasty.
Materials and Methods 
Study population
In this double blind randomized clinical trial, 34 patients 
(2 groups) referred for elective PTCA were randomly 
divided to  “intervention” and “control” groups. The 
study was carried out in Shahid Madani Heart hospital in 
Khorramabad, Iran between February 2016 to December 
2017. The study protocol was approved by the medical 
ethics  research committee of Lorestan University of 
Medical Sciences and written informed consent was 
obtained from each patient. All patients had stable 
angina when underwent coronary angioplasty. Patients 
were included if they had isolated obstructive lesion in 
at least one coronary artery branch with ≥70% reduction 
in the luminal diameter. Patients who had allergy to 
ginger, episode(s) of chest pain in 48 hours before 
PTCA, Prinzmetal angina, conduction defects on the 
ECG and baseline ST-segment deviations on the surface 
electrocardiography (ECG) were excluded from study. 
Both control and ginger groups consisted of 16 patients 
(men and women, respectively). The last episode of chest 
pain in all patients occurred in 48 hours before PTCA.
Study protocol
In this double-blind  randomized clinical trial each 
patient in the intervention (ginger) group received ginger 
capsules (250 mg, orally of Goldaru, Isfahan, Iran) daily 
and the same samples from the placebo group received 
starch capsules (250 mg, orally  Goldaru, Isfahan, Iran) 
daily since 10 days before angioplasty. The diagnostic 
angiography was performed and nonionic contrast agent 
(Visipaque GE, Healthcare Ireland, osmolarity: 320 mg/
mL) was administrated intravenously for each patient. 
After diagnostic angiography, the patients who had 
isolated obstructive lesion in at least one coronary artery 
branch with ≥70% reduction in the luminal diameter 
underwent coronary angioplasty. The PTCA procedure 
was performed by routine technique using the femoral 
approach: After prep and drape, heparin (2000 IU) was 
administered intravenously before coronary angioplasty. 
Then, balloon was positioned across the lesion and one 
session of balloon inflation was done for45   second 
followed by two minute of reperfusion. The balloon 
inflation pressure ranged from 11 to 14 atmospheres. At 
the end of the procedure, angioplasty balloon deflated 
and was withdrawn from the stenotic site and after 2 
min reperfusion the study protocol was finished. Similar 
procedures were done in control group. The cardiologist 
who applied angiography and angioplasty procedures was 
blind about the patient’s group.
Laboratory measurements
Venous blood samples were obtained from each patient 
before and 12 hours following PTCA procedure to measure 
troponin I as biomarker of cardiac cell injury. Troponin 
I activities were measured by standard kits (RAMP 
Vancouver, Canada) using an auto-analyzer and expressed 
as nano gram per milliliter (ng/mL). The normal values 
of cardiac troponin 1 (cTnI) were considered to be ≤0.1 
ng/mL.
Assessment of chest pain
At the end of balloon inflation the severity of chest pain 
was assessed by numeric rating scale (NRS) by a nurse 
who had no knowledge about the patient’s group. The 
patients were asked to say the severity of chest pain on a 
scale of 0 (no pain) to 10 (severe pain).
Statistical analysis
Biomarkers data are expressed as mean plus standard 
deviations. All chest pain score data are shown in the 
relevant figures and the median is also presented. 
Statistical analysis of data within groups was performed 
with the Mann-Whitney test and the changes within 
groups were analyzed by the Wilcoxon t test. Statistical 
significance was defined as P < 0.05.
Results
The demographic characteristics of the control and the 
intervention groups are summarized in Table 1. There 
were no statistically significant differences between 
the two groups in terms of the determined parameters. 
Angioplasty was successfully performed in all patients. 
Table 1. Clinical characteristics of the patients in the two groups
Variable Control group (n)
Intervention group 
(n)
Gender, M/F 13/4 9/8
Hypertension, n 10  9
Smoking, n 11  8 
Diabetes mellitus, n 5  5 
Previous CABG, n 4 2
Previous MI, n 4 4 
EF above 50% 11 9
EF below 50% 6 8
Use of Long-acting nitrates 4 1
Use of beta-blocker agents 9 5
Glibenclamide usage 3  2
n = number of patients.
CABG: Coronary artery bypass graft; MI: myocardial infarction; EF: left 
ventricular ejection fraction.
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There were no statistically significant differences between 
the two groups in the determined parameters.
Chest pain
The average pain score during the balloon inflation in 
the ginger group was 2.1±1 and in the control group was 
3.8±1.5 (2.1±1 versus 3.8±1.5, P=0.04). The pain score 
between the two groups is significantly different.
Cardiac biomarkers
Troponin level changed from 1.4±1.1 ng/mL to 0.51±0.62 
in the ginger group and from 1.4±1.1 to 0.89±0.92 in 
the control group. There were no significant differences 
between the values of troponin I in the two groups before 
and after angioplasty (P = 0.10) (Table 2).
Discussion
The results of the present study showed that usage of 250 
mg ginger  during 10 days before PTCA reduces chest 
pain but has no effect on release of cardiac biomarkers. 
In some studies, troponin I has been analyzed after 
angioplasty as hallmarks of cardiac cell injury (16,17). In 
these studies the relationship between biomarker changes 
after coronary angioplasty and the patients’ outcome was 
assessed (18,19). Ginger has a lot of valuable compounds 
and has used for medicinal purposes for several hundred 
years. In recent years the results of clinical trials 
indicated that ginger is an all-purpose plant in medicine 
field such as cardiovascular disease. In addition, it has 
been proposed that ginger possesses antioxidant, anti-
inflammatory, glucose, cholesterol and lipid-lowering, 
anti-platelet, hypotensive and positive inotropic effects 
(20-25). Based on the anti-inflammatory effect of ginger 
this hypothesis was extracted that ginger might be used 
in reducing IRI. In recent years the ginger has been a 
new agent determined in reducing IRI in rat kidney 
(7,8). A number of pharmacological agents like estrogen, 
bradykinin and enalapril have been shown to be cardio-
protective in patients undergoing PTCA by determination 
of ST segment changes, echocardiography findings and the 
severity of chest pain (26,27). The present study tested the 
effect of ginger in reducing IRI in human heart in patients 
undergoing angioplasty. We measured the chest pain score 
and troponin values as indicators of myocardial damage. 
In many clinical trials the pharmacologic preconditioning 
reduced chest pain and release of troponin that were 
considered as reflects of cardio-protective effect (26,27). 
The ST changes were not measured in the present study 
and the cardiac biomarkers were measured instead 
of ST changes values. In a similar study, oxygen was 
administrated prior to elective angioplasty which had 
no effect on cardiac biomarkers level but reduced chest 
pain. In that study the authors did not include a placebo 
and this factor could affect the accuracy of the pain score 
that is a subjective endpoint (28). In this study, placebo 
was used to minimize the effects of confounding factor to 
measure pain score. The mechanism of ginger in reducing 
ischemia reperfusion injury is not fully understood but 
the free radical scavenger has been proposed (7,8). 
In conclusion the use of ginger can reduce chest pain 
during coronary angioplasty and because of its convenient 
use and no significant complications; it might be a good 
therapeutic agent in clinical practice.
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